ACCC submits letter to the Centers for Medicare and Medicaid Services (CMS) on the proposed Global Benchmark for Efficient Drug Pricing (GLOBE) Model

Among other cancer treatments, many ACCC members provide physician-administered cancer medicines, such as those proposed to be included in the Global Benchmark for Efficient Drug Pricing (GLOBE) Model. ACCC respectfully offers the following comments to CMS in response to the proposed rule.

Read the Letter